Evaluation of Cisplatin-Induced Acute Renal Failure Amelioration Using Fondaparinux and Alteplase

Evaluation of Cisplatin-Induced Acute Renal Failure Amelioration Using Fondaparinux and Alteplase

Acute renal failure (ARF) is a deleterious condition with increased mortality or healthcare costs or dialysis-dependent end-stage renal disease. The study aims to compare prophylaxis with fondaparinux (Fund) vs. treatment with alteplase (Alt) in ameliorating cisplatin (Cis)-induced ARF. Sixty male m...

Full description

Bibliographic Details
Main Authors: Mohamed S. Abdel-Bakky, Anas S. A. Aldakhili, Hussein M. Ali, Ali Y. Babiker, Ahmad H. Alhowail, Salman A. A. Mohammed
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Pharmaceuticals
Subjects:
fondaparinux
cisplatin
alteplase
acute kidney failure
apoptosis
protein expression
Online Access:https://www.mdpi.com/1424-8247/16/7/910

Internet

https://www.mdpi.com/1424-8247/16/7/910

Similar Items